Digitek

About Digitek

PDF Print

Deli.cio.us    Digg    reddit    Facebook    StumbleUpon    Newsvine

Digitek, also known as Digoxin, is derived from the leaves of a digitalis plant. Digoxin helps make the heart beat stronger and with a more regular rhythm.

Digoxin is used to treat congestive heart failure.

Digoxin is also used to treat atrial fibrillation, a heart rhythm disorder of the atria (the upper chambers of the heart that allow blood to flow into the heart).

 

 FDA Recall of Digitek

The April 2008 nationwide Digitek recall was based on side effects due to a possible double-dosage of the drug’s active ingredient, present in some of the oral Digitek tablets on the U.S. market.

 

Serious Digitek Side Effects:

  • bradycardia (abnormally slow heart beat)
  • cardiac instability
  • nausea
  • dizziness
  • low blood pressure (hypotension)
  • vomiting

 

Other Symptoms and Side Effects: 

  • abdominal pain
  • adverse cardiac effects
  • confusion and mental disturbances (e.g., hallucinations, anxiety, delirium, and depression)
  • diarrhea
  • dizziness
  • gynecomastia (enlargement of male breasts)
  • hemorrhagic necrosis of the intestines
  • intestinal ischemia
  • maculopapular rash (a flat, red areas on the skin covered with small bumps, as in measles)
  • nausea and vomiting
  • thrombocytopenia (low platelet count in the blood, making an increased risk of bleeding)
  • visual disturbances (blurred or yellow vision; the appearance of blurred outlines/halos)

 

 

Attorneys move to close Actavis NJ facilities

PDF Print

Deli.cio.us    Digg    reddit    Facebook    StumbleUpon    Newsvine

The Associated Press

NEW YORK (AP) — U.S. Attorneys in New Jersey on Friday filed a lawsuit seeking a shutdown of three Actavis Inc. plants until they are brought into compliance with testing, manufacturing laws and FDA regulations.

The complaint requests that the court prevent Actavis Inc., Actavis Totowa, and executives Sigurdur Olafsson and Douglas Boothe from being involved in the making of drugs until the company is brought into compliance with Food and Drug Administration requirements for testing, quality control and test response, and ceases selling unapproved and misbranded drugs.

Read more... [Attorneys move to close Actavis NJ facilities]
 


© 2008 leflaw.com design by tracy feldman